Catalyst Wire Dossier Catalyst Wire Dossier

Calcipotriene/Betamethone Dipropionate PAD Cream

calcipotriene/betamethasone dipropionate · Almirall, S.A.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Calcipotriene/Betamethone Dipropionate PAD Cream, covering 2025-09-24 to 2025-09-24. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Assess Treatment Satisfaction, Patient-reported Outcomes, Effectiveness, and Safety of a Fixed-dose Combination of Calcipotriene/Betamethasone Dipropionate PAD Cream in the Treatment of Mild-to-moderate Plaque Psoriasis of the Scalp in Adults

See pricing